Article
Evolutionary Convergence on a Dihydrofolate Reductase Mutation Drives Trimethoprim-Sulfamethoxazole Resistance in Burkholderia thailandensis.
ACS infectious diseases - 14 Aug 2026
Guillier Sophie, Lazennec-Schurdevin Christine, Mondange Lou, Sarilar Véronique, Marchandeau Mélissa, Lemoigne Chloé, Lamer Ombeline, Lescat Mathilde, Schmitt Emmanuelle, Mechulam Yves, Garrec Julian, Biot Fabrice
Abstract excerpt
Trimethoprim-sulfamethoxazole (SXT) remains central to melioidosis eradication therapy, yet the genetic basis of resistance evolution in Burkholderia pseudomallei is not fully defined. Using Burkholderia thailandensis as a biosafe surrogate, we subjected populations to stepwise in vitro evolution under increasing SXT concentrations. Whole-genome sequencing revealed rapid population diversification followed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
